Assessing depression in fibromyalgia patients

Area of Science:

• Psychiatry
• Rheumatology
• Medical Diagnostics

Background:

• Fibromyalgia is a chronic condition often accompanied by depression.
• Accurate depression detection is crucial for effective fibromyalgia management.
• Various screening tools exist, but their comparative performance in fibromyalgia is not well-established.

Purpose of the Study:

• To investigate the relationships among four distinct methods for detecting depression in patients diagnosed with fibromyalgia.
• To compare the diagnostic accuracy, sensitivity, and specificity of these methods.

Main Methods:

• A cohort of 100 women diagnosed with fibromyalgia (mean age 43) participated.
• Four depression assessment instruments were utilized: Computerized Diagnostic Interview Schedule (C-DIS), Beck Depression Inventory (BDI), adjusted BDI (BDI-A), and Minnesota Multiphasic Personality Inventory depression subscale (MMPI-D).
• Statistical analyses included chance-corrected concordance, sensitivity, specificity, and accuracy calculations.

Main Results:

• The Computerized Diagnostic Interview Schedule (C-DIS) identified 22% and the adjusted BDI (BDI-A) identified 29% with major depression.
• The Beck Depression Inventory (BDI) and MMPI-D reported higher prevalence rates of 55% and 44%, respectively.
• All four methods demonstrated agreement significantly above chance.
• The BDI exhibited the highest sensitivity, while the BDI-A showed the greatest specificity when compared against the C-DIS.

Conclusions:

• The Beck Depression Inventory (BDI) is a sensitive tool for detecting depression in fibromyalgia patients.
• The adjusted Beck Depression Inventory (BDI-A) offers superior specificity in this patient population.
• Clinicians should consider the varying sensitivity and specificity profiles of different depression screening tools when assessing fibromyalgia patients.